Cowen Prime Advisors’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Cowen Prime Advisors’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,200	Closed	-$88K	–	260
2016 Q3	$88K	Buy	+4,200	New	+$48.4K	0.04%	139

Cowen Prime Advisors's VTAE Position: Q4 2016 in Review

Cowen Prime Advisors sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 4,200 shares — an estimated $88K sold.

Cowen Prime Advisors first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $88K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Cowen Prime Advisors reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Cowen Prime Advisors sold 4,200 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $88K.
Cowen Prime Advisors first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Cowen Prime Advisors's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $88K in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Cowen Prime Advisors's 13F filing for Q4 2016, filed 9 Feb 2017.